Frequency of depression among fertile and infertile women

To compare the frequency of depression among fertile and infertile women reporting in CMH Abbottabad. A case control study. This study was conducted in combined military hospital abbottabad, over a period of six months from January 2013 to June 2013. The inclusion criteria were all those patients who were married. All the cases were selected from the women reporting in the obstetrics and gynecology department of CMH Abbottabad for investigation and treatment of infertility. A total of 200 patients, 100 fertile and 100 infertile women were included. Patients were given questionnaire form with their consent for research. Beck depression inventory [BDI] was used to assess depression among fertile and infertile women. Other factors such as age, education level, and duration of infertility, pressure from family members, miscarriages, and support from husband were studied. Depression was significantly higher in infertile women as compared to fertile women i.e. 95% vs. 63% [p<0.001]. It was higher among women with more than 1 year of duration of marriage as compared to those with infertility of one year duration or less. Infertility is associated with depression

Comparison between sublingual misoprostol and intramyometrial prostaglandin F2A in adjunct to routine management of primary postpartum hemmorhage

To study the efficacy of sublingual misoprostol as compared with injectable PGF2alpha in management of primary Post Partum hemorrhage [PPH]. Randomized controlled trial. Combined Military Hospital Risalpur, from January 2006 to September 2008. All patients who reported to CMH Risalpur were included except women with previous cesarean section and those with gestational age less than twenty eight weeks at the time of delivery. They were randomized in two equal groups of thirty patients each. One group received 600mcg sublingual misoprostol [Parke-Davis] combined with standard oxytocic treatment and the other group received intramyometrial PGF2alpha [Prostin F2alpha, Dinoprost- Parke-Davis] combined with standard oxytocic for treatment of primary PPH. There was insignificant difference between both groups in terms of blood loss [p>0.05], treatment failure [p=0.640] and side effects [p=0.05]. Sublingual misoprostol was found to be equally effective as compared to intramyometrial PGF2 alpha for the treatment of primary PPH but superior when price, availability and storage are taken into account